Archive · 4 Sep 2026
Singapore Cancer Centre Reports Nearly 20% Rise in Indian Patients
More Indian patients went to a cancer centre in Singapore in 2025.
The centre said their number increased by nearly 20 percent.
Many of these patients had cancer that was already advanced or had not responded to treatment.
This can make curing the disease more difficult.
Doctors said finding the exact type of cancer is very important.
Tests can include scans, biopsies and checks for genetic changes in the cancer.
Some advanced cancers can still be controlled for many years with the right treatment.
The doctor also said preventing tobacco and betel nut use and finding cancer early can improve outcomes.
Parkway Cancer Centre reported nearly 20% year-on-year growth in Indian patients in 2025.
Dr Ang Peng Tiam said 60–70% of Indian patients arrive with advanced or treatment-resistant cancer.
Only about 30% of Indian patients seen by the centre are potentially at a curable stage.
Diagnostic workups, including imaging, biopsy, pathology and molecular profiling, are usually completed within 48 hours.
Treatment costs vary widely, with some medicines ranging from a few hundred to SGD 14,000 per cycle.
- Who
- Parkway Cancer Centre and its medical director, Dr Ang Peng Tiam, discussed care for Indian cancer patients.
- What
- The Singapore-based centre reported a nearly 20% increase in Indian patients in 2025, most of whom had advanced or treatment-resistant cancer.
- When
- In 2025; the report was published on September 4.
- Where
- At Parkway Cancer Centre in Singapore, with the report datelined Kolkata, India.
- Why
- Many patients travel abroad after available treatment options in India have been exhausted or to seek another medical perspective.
- Patient growth
- Indian patient numbers at Parkway Cancer Centre rose by nearly 20% year on year in 2025.
- Advanced cases
- About 60–70% of Indian patients had advanced or treatment-resistant cancers.
- Potentially curable cases
- About 30% were potentially at a curable stage.
- Diagnostic timeline
- The centre aims to complete imaging, biopsy, pathology and molecular profiling within 48 hours in most cases.
- Treatment costs
- Drug costs can range from a few hundred Singapore dollars to SGD 14,000 per cycle.
- Treatment duration
- Some chemotherapy patients may receive six cycles, typically one every 21 days, while others need longer treatment.
- Indian outreach
- Parkway Cancer Centre operates a CanHOPE office in Delhi focused on cancer awareness, prevention, detection and care.